STAAR Surgical Defends Merger, Shares Jump
Update: 2025-12-11
Description
STAAR Surgicals shares surged by nearly four percent following the companys defense of its planned merger with Alcon, refuting claims from activist investors. The companys management asserted that allegations of blocking a potential buyer were patently false. Alcon increased its offer to $30.75 per share, a 74% premium over STAARs average stock price. Despite the initial rise, STAARs shares settled slightly, still up over three and a half percent. The company encourages stockholders to approve the merger at a special meeting in December.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
